WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2009067409) 2',4'-SUBSTITUTED NUCLEOSIDES AS ANTIVIRAL AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2009/067409    International Application No.:    PCT/US2008/083787
Publication Date: 28.05.2009 International Filing Date: 17.11.2008
IPC:
C07H 19/06 (2006.01), C07H 19/16 (2006.01), A61K 31/7068 (2006.01), A61K 31/7076 (2006.01), A61P 31/12 (2006.01)
Applicants: PHARMASSET, INC. [US/US]; 303A College Road East, Princeton, NJ 08540 (US) (For All Designated States Except US).
SOFIA, Michael, J. [US/US]; (US) (For US Only).
DU, Jinfa [US/US]; (US) (For US Only)
Inventors: SOFIA, Michael, J.; (US).
DU, Jinfa; (US)
Agent: SKOOG, Mark, T.; Merchant & Gould P.c., P.O. Box 2903, Minneapolis, MN 55402-0903 (US)
Priority Data:
60/989,296 20.11.2007 US
12/271,388 14.11.2008 US
Title (EN) 2',4'-SUBSTITUTED NUCLEOSIDES AS ANTIVIRAL AGENTS
(FR) NUCLÉOSIDES SUBSTITUÉS EN POSITION 2',4' EN TANT QU'AGENTS ANTIVIRAUX
Abstract: front page image
(EN)Embodiments of the invention are to compounds of formulae (A), (A'), methods, and compositions for use in the treatment of viral infections. More specifically embodiments of the invention aur 2 ', 4 ' -substituted nucleoside compounds useful for the treatment of viral infections, such as HIV, HCV, and HBV infections.
(FR)L'invention concerne, dans des modes de réalisation, des composés, des procédés, et des compositions destinés à être utilisés dans le traitement d'infections virales. De façon plus précise, des modes de réalisation de l'invention sont des composés de nucléoside substitués en position 2',4' utiles pour le traitement d'infections virales, telles que les infections par le VIH, le VHC, et le VHB.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)